Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | KCNH2 | Q12809 | 8/20 | 1.00 |
| ▸ | CYP2D6 | P10635 | 6/20 | 1.00 |
| ▸ | ADORA2A | P29274 | 5/20 | 1.00 |
| ▸ | ADORA1 | P30542 | 5/20 | 1.00 |
| ▸ | CYP3A4 | P08684 | 4/20 | 1.00 |
| ▸ | CYP1A2 | P05177 | 4/20 | 1.00 |
| ▸ | CYP2C19 | P33261 | 3/20 | 1.00 |
| ▸ | ADORA3 | P0DMS8 | 2/20 | 1.00 |
| ▸ | ADORA2B | P29275 | 1/20 | 1.00 |
| ▸ | ABCG2 | Q9UNQ0 | 1/20 | 1.00 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 1.00 |
| ▸ | NR1I2 | O75469 | 1/20 | 1.00 |
| ▸ | LMNA | P02545 | 1/20 | 1.00 |
| ▸ | TP53 | P04637 | 1/20 | 1.00 |
| ▸ | HTR1A | P08908 | 1/20 | 1.00 |
| ▸ | TSHR | P16473 | 1/20 | 1.00 |
| ▸ | CNR1 | P21554 | 1/20 | 1.00 |
| ▸ | GLRA1 | P23415 | 1/20 | 1.00 |
| ▸ | SLC6A2 | P23975 | 1/20 | 1.00 |
| ▸ | HTR2A | P28223 | 1/20 | 1.00 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| (S,R)-Mefloquine SCHEMBL32385911 | 1.00 | KCNH2 (1.00) | KCNH2CYP2D6ADORA2AADORA1CYP3A4 | |
| (S,R)-Mefloquine SCHEMBL16702641 | 1.00 | KCNH2 (1.00) | KCNH2CYP2D6ADORA2AADORA1CYP3A4 | |
| Mefloquine SCHEMBL8575605 | 1.00 | KCNH2 (1.00) | KCNH2CYP2D6ADORA2AADORA1CYP3A4 | |
| (R,R)-Mefloquine SCHEMBL21781 | 1.00 | KCNH2 (1.00) | KCNH2CYP2D6ADORA2AADORA1CYP3A4 | |
| Mefloquine SCHEMBL17087807 | 1.00 | KCNH2 (1.00) | KCNH2CYP2D6ADORA2AADORA1CYP3A4 | |
| (S,S)-Mefloquine SCHEMBL7278974 | 1.00 | KCNH2 (1.00) | KCNH2CYP2D6ADORA2AADORA1CYP3A4 | |
| Mefloquine SCHEMBL3625982 | 1.00 | KCNH2 (1.00) | KCNH2CYP2D6ADORA2AADORA1CYP3A4 | |
| Mefloquine SCHEMBL21782 | 1.00 | KCNH2 (1.00) | KCNH2CYP2D6ADORA2AADORA1CYP3A4 | |
| Mefloquine SCHEMBL7130867 | 1.00 | KCNH2 (1.00) | KCNH2CYP2D6ADORA2AADORA1CYP3A4 | |
| Mefloquine SCHEMBL29433990 | 1.00 | KCNH2 (1.00) | KCNH2CYP2D6ADORA2AADORA1CYP3A4 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Appears in 17115 patents — a generic fragment claimed broadly, so it's down-weighted as IP noise. Top by claim status then date:
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-122094963-A | Cardioprotective lipids and methods of use | — | 2026-05-26 | — | — | CN | claimed |
| EP-4741492-A2 | NECROSIS INHIBITOR | Linkgevity Limited (GB) | 2026-05-13 | — | — | EP | claimed |
| EP-4255391-B1 | LUMINOL FOR USE IN THE TREATMENT OF SEQUELAE OF A SARS-COV-2 INFECTION | METRIOPHARM AG (CH) | 2026-05-06 | — | — | EP | claimed |
| EP-4727549-A2 | PLASMODIUM FALCIPARUM BLOOD STAGE INHIBITORS | University of Georgia Research Foundation, Inc. (US) | 2026-04-22 | — | — | EP | claimed |
| EP-4680248-A1 | PRODUCTS OF MANUFACTURE AND THERAPEUTIC COMPOSITIONS FOR TREATING, AMELIORATING OR PREVENTING VIRAL INFECTIONS AND METHODS FOR MAKING AND USING THEM | Topelia Aust Limited (ACN 652 771 670) (AU) | 2026-01-21 | — | — | EP | claimed |
| EP-4680608-A1 | 2,6-DIHYDRO-7H-PYRAZOLO[3,4-C]PYRIDIN-7-ONE DERIVATIVES AS ANTI-MALARIAL AGENTS | MMV Medicines for Malaria Venture (CH) | 2026-01-21 | — | — | EP | claimed |
| EP-4674894-A2 | COPOLYMERS OF N-VINYLPYRROLIDONE WITH FUNCTIONALIZED MALEIC ACID MOIETIES | Hemoteq AG (DE) | 2026-01-07 | — | — | EP | claimed |
| US-12509439-B2 | Anti-malarial agents | UNIVERSITY OF KENTUCKY RESEARCH FOUNDATION (US) | 2025-12-30 | — | — | US | claimed |
| US-20250388603-A1 | ANTIMALARIAL COMPOUNDS | SCRIPPS RESEARCH INST (US) | 2025-12-25 | — | — | US | claimed |
| EP-4663688-A2 | CROSSLINKERS | Hemoteq AG (DE) | 2025-12-17 | — | — | EP | claimed |
| WO-1989008658-A1 | SUBSTITUTED ADENINE DERIVATIVES USEFUL AS THERAPEUTIC AGENTS | SCRIPPS CLINIC AND RESEARCH FOUNDATION (US) | 1989-09-21 | — | — | WO | claimed |
| EP-0332657-A1 | ANTIMALARIAL COMPOSITIONS AND METHODS | The Department of the Army Engineer Research and Development Center, Corps of Engineers (US) | 1989-09-20 | — | — | EP | claimed |
| EP-0332657-A4 | ANTIMALARIAL COMPOSITIONS AND METHODS. | US SEC THE ARMY INTELLECTUAL P (US) | 1989-08-22 | — | — | EP | claimed |
| US-4826689-A | PRECIPITATION FROM SOLUTION IN ORGANIC SOLVENT | UNIVERSITY OF ROCHESTER (US) | 1989-05-02 | — | — | US | claimed |
| WO-1988003802-A1 | ANTIMALARIAL COMPOSITIONS AND METHODS | UNITED STATES OF AMERICA, AS REPRESENTED BY THE SE (US) | 1988-06-02 | — | — | WO | claimed |
| EP-0092185-B1 | MEFLOQUINE-HYDROCHLORIDE AND PROCESS FOR ITS HIGH PURITY PREPARATION | F. HOFFMANN-LA ROCHE & CO. Aktiengesellschaft (CH) | 1988-04-20 | — | — | EP | claimed |
| EP-0169618-A2 | Method for making uniformly sized particles from water-insoluble organic compounds | STERILIZATION TECHNICAL SERVICES, Inc. (US) | 1986-01-29 | — | — | EP | claimed |
| EP-0154491-A2 | Quinate salts of the antimalarial compound mefloquine | SMITHKLINE BEECHAM CORPORATION (US) | 1985-09-11 | — | — | EP | claimed |
| EP-0001796-B1 | ANTI-MALARIA DRUG | HOECHST AKTIENGESELLSCHAFT (DE) | 1981-06-10 | — | — | EP | claimed |
| EP-0001796-A1 | Anti-malaria drug | HOECHST AKTIENGESELLSCHAFT (DE) | 1979-05-16 | — | — | EP | claimed |